Rachel Wiser Runs NYC Half-Marathon for LRA in Honor of Her Childhood Friend
Rachel Wiser is running the United Airlines NYC Half marathon with the Lupus Research Alliance (LRA) Team Life Without...
LRA
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio,...
New COVID-19 Vaccine Clinical Guidance and Planned Research
Important news for people with lupus as COVID-19 vaccines are on everyone’s minds. The foremost authority in rheumatologic diseases,...
2019 Lupus Insight Prize Awarded to Ignacio Sanz, MD
Thinking outside the box” is jargon that often rings hollow—but not so when it’s used to describe the ideas...
Leading with Extraordinary Clarity and Grace
Leading with Extraordinary Clarity and Grace
The LRA is enormously grateful to Mary K. (Peggy) Crow, MD for her more...
Lupus News Corner
BIG … BOLD … IDEAS ARE TRANSFORMING LUPUS RESEARCH—thanks to people like you!
Thanks to our remarkable supporters, the Lupus...
LRA-Funded Discovery May Benefit Alzheimer’s Disease
August 1, 2019
A new study by LRA Distinguished Innovator Award recipient Dr. Douglas Green of St. Jude Children’s Research...
Lupus Research Alliance Congratulates Dr. Betty Diamond for Well-Deserved Recognition by AAI
May 20, 2019
The LRA applauds Betty Diamond, MD for being named a Distinguished Fellow by the American Association of...
Illuminating the Microbiome’s Role in Lupus
May 15, 2019
One of the biggest questions in lupus is why the immune system tries to destroy patients’ own...
Seeing Our Research Through a Fresh Lens With Dr. Gary Koretzky
April, 2019
The Lupus Research Alliance is proud to welcome renowned expert in rheumatology and immunology, Gary Koretzky, MD, PhD,...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...